ArticlePediatric dermatology

A Phase 1, Open-Label Study of the Pharmacokinetics of Ritlecitinib in Children Aged 6-12 Years With Alopecia Areata.

Mercedes E Gonzalez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.